Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: Correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model

Experimental Cell Research

Volumn 272, Issue 2, 2002, Pages 185-191

  Ding, Zhihu ^a   Green, Adam G ^a   Yang, Xiaolong ^a   Chernenko, Garry ^a   Tang, Shou Ching ^a,b   Pater, Alan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Dr H Bliss Murphy Cancer Center   (Canada)

Author keywords

All trans retinoic acid; Cell growth rate; Cervical cells; hTERT; Immortalization; Telomerase; Transformation multidrug resistance

Indexed keywords

MESSENGER RNA; RETINOIC ACID; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BIOTRANSFORMATION; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG INHIBITION; ELECTRIC POTENTIAL; ENZYME ACTIVITY; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SPLICEOSOME; UTERINE CERVIX CARCINOMA;

ATRA;

EID: 0036060531     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5412     Document Type: Article

References (52)

1. Telomeres and senescence: Ending the debate
2. Telomere length maintenance in aging and carcinogenesis
3. Telomerase activity in human germline and embryonic tissues and cells
4. Telomerase activity in normal leukocytes and in hematologic malignancies
5. Telomerase activity in normal human epithelial cells
6. Regulation of telomerase activity in immortal cell lines
7. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
8. Telomeres, telomerase, and cancer: Life on the edge of genomic stability
9. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance
10. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells
11. Retinoids in chemoprevention and differentiation therapy
12. Retinoic acid extends the in vitro life span of normal human oral keratinocytes by decreasing p16(INK4A) expression and maintaining telomerase activity
13. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
14. Telomerase catalytic subunit homologs from fission yeast and human
15. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
16. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
17. The RNA component of human telomerase
18. Essential role of mouse telomerase in highly proliferative organs
19. Severe growth defect in mouse cells lacking the telomerase RNA component
20. A mammalian telomerase-associated protein
21. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
22. Estimates of the worldwide mortality from 25 cancers in 1990
23. Estimates of the worldwide incidence of 25 major cancers in 1990
24. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis
25. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells
26. Human papillomavirus type 16-immortalized endocervical cells selected for resistance to cisplatin are malignantly transformed and have a multidrug resistance phenotype
27. Malignant transformation of human ectocervical cells immortalized by HPV 18: In vitro model of carcinogenesis by cigarette smoke
28. Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix
29. Specific association of human telomerase activity with immortal cells and cancer
30. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
31. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
32. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)
33. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids
34. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells
35. Clinical implications of telomerase in cancer
36. Role of retinoids in differentiation and carcinogenesis
37. Inhibitory effects of retinoids on development of squamous metaplasia in rat mammary epithelial organoids cultured in Matrigel
38. All-trans retinoic acid induced differentiation of rat mammary epithelial cells cultured in serum-free medium
39. Prevention of carcinoma in situ of human papillomavirus type 16-immortalized human endocervical cells by retinoic acid in organotypic raft culture
40. Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses
41. Application of telomerase assay for the screening of cervical lesions
42. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: Strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA
43. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
44. Telomerase activation in in vitro and in vivo cervical carcinogenesis
45. Extension of life-span by introduction of telomerase into normal human cells
46. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
47. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
48. The effect of all-trans and 9-cis retinoic acid on the steady state level of HPV16 E6/E7 mRNA and cell cycle in cervical carcinoma cells
49. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
50. Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites
51. Myc activates telomerase
52. Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells